Excessive proteostasis contributes to pathology in fragile X syndrome
Neuron · 2023-02 · 111 (4) · 508-525.e7
DOI: 10.1016/j.neuron.2022.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2023-02. Verfasst von Susana R Louros und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK; Simons Initiative for the D…. Hauptthemen laut MEDLINE: Fragile X Syndrome. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
In fragile X syndrome (FX), the leading monogenic cause of autism, excessive neuronal protein synthesis is a core pathophysiology; however, an overall increase in protein expression is not observed. Here, we tested whether excessive protein synthesis drives a compensatory rise in protein degradation that is protective for FX mouse model (Fmr1-/y) neurons. Surprisingly, although we find a significant increase in protein degradation through ubiquitin proteasome system (UPS), this contributes to pathological changes. Normalizing proteasome activity with bortezomib corrects excessive hippocampal protein synthesis and hyperactivation of neurons in the inferior colliculus (IC) in response to auditory stimulation. Moreover, systemic administration of bortezomib significantly reduces the incidence and severity of audiogenic seizures (AGS) in the Fmr1-/y mouse, as does genetic reduction of proteasome, specifically in the IC. Together, these results identify excessive activation of the UPS pathway in Fmr1-/y neurons as a contributor to multiple phenotypes that can be targeted for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK; Simons Initiative for the Developing Brain, University of Edinburgh, Hugh Robson Building, George…
- Department of Molecular and Cellular Neurobiology, Centre for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- CRUK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Förderung
- Medical Research Council
- Wellcome Trust
Zitieren
APA
Louros, S. R., Seo, S. S., Maio, B., Martinez-Gonzalez, C., Gonzalez-Lozano, M. A., Muscas, M., Verity, N. C., Wills, J. C., Li, K. W., Nolan, M. F., & Osterweil, E. K. (2023). Excessive proteostasis contributes to pathology in fragile X syndrome. Neuron, 111(4), 508-525.e7. https://doi.org/10.1016/j.neuron.2022.11.012
Vancouver
Louros SR, Seo SS, Maio B, Martinez-Gonzalez C, Gonzalez-Lozano MA, Muscas M, et al. Excessive proteostasis contributes to pathology in fragile X syndrome. Neuron. 2023;111(4):508-525.e7. doi:10.1016/j.neuron.2022.11.012
BibTeX
@article{Louros2023,
author = {Louros, Susana R and Seo, Sang S and Maio, Beatriz and Martinez-Gonzalez, Cristina and Gonzalez-Lozano, Miguel A and Muscas, Melania and Verity, Nick C and Wills, Jimi C and Li, Ka Wan and Nolan, Matthew F and Osterweil, Emily K},
title = {Excessive proteostasis contributes to pathology in fragile X syndrome},
journal = {Neuron},
year = {2023},
volume = {111},
number = {4},
pages = {508--525.e7},
doi = {10.1016/j.neuron.2022.11.012}
}
EUVIMED